unknown
Stage
1
Investors
About
AtriAN Medical develops a novel cardiac treatment using pulsed field ablation to target and disable specific neurons on the heart's epicardial surface, aiming to provide a more durable and safer therapy for atrial fibrillation.
Explore AtriAN Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.